BeOne Medicines (ONC) Asset Utilization Ratio (2016 - 2026)

BeOne Medicines (ONC) has reported Asset Utilization Ratio for 11 consecutive years, with 0.69 the latest figure, recorded in Q1 2026.

• In Q1 2026, Asset Utilization Ratio fell 3.44% year-over-year to 0.69; the TTM figure through Mar 2026 stood at 0.69 (down 3.44% YoY), while the FY2025 annual figure was 0.76, up 16.54% from the prior year.
• Asset Utilization Ratio improved to 0.69 in Q1 2026 per ONC's latest filing, from 0.68 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.75 in Q2 2025 and bottomed at 0.11 in Q1 2022.
• Historically, Asset Utilization Ratio has averaged 0.46 across 5 years, with a median of 0.48 in 2024.
• Annual changes were most pronounced in 2022 — Asset Utilization Ratio slipped 29.87% — and 2023, when it surged 157.0%.
• BeOne Medicines' Asset Utilization Ratio stood at 0.23 in 2022, then surged by 87.09% to 0.43 in 2023, then surged by 49.41% to 0.65 in 2024, then gained by 4.16% to 0.68 in 2025, then rose by 1.51% to 0.69 in 2026.
• Business Quant data shows ONC's Asset Utilization Ratio at 0.69 in Q1 2026, 0.68 in Q4 2025, and 0.71 in Q3 2025.